XML 27 R17.htm IDEA: XBRL DOCUMENT

Capital Stock	3 Months Ended
Mar. 31, 2022
Equity [Abstract]
Capital Stock	11. CAPITAL STOCK As of March 31, 2022, the Company was authorized to issue 450,000,000 shares of common stock of which 10,800,278 were issued and outstanding. The Company was also authorized to issue 50,000,000 shares of preferred stock, $0.01 par value, of which none has been issued. On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”) pursuant to which the Company may sell, from time to time, shares of common stock having an aggregate offering price of up to $15,000,000, through the Agent. As of March 31, 2022, under the Sales Agreement, the Company has sold and issued an aggregate of 65,843 shares of common stock and raised aggregate gross proceeds of approximately $403,364, less sales commissions of approximately $8,069 and other offering costs resulting in net proceeds of $198,370.

Capital Stock

3 Months Ended

Mar. 31, 2022

11. CAPITAL STOCK

As of March 31, 2022, the Company was authorized to issue 450,000,000 shares of common stock of which 10,800,278 were issued and outstanding. The Company was also authorized to issue 50,000,000 shares of preferred stock, $0.01 par value, of which none has been issued.

On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”) pursuant to which the Company may sell, from time to time, shares of common stock having an aggregate offering price of up to $15,000,000, through the Agent. As of March 31, 2022, under the Sales Agreement, the Company has sold and issued an aggregate of 65,843 shares of common stock and raised aggregate gross proceeds of approximately $403,364, less sales commissions of approximately $8,069 and other offering costs resulting in net proceeds of $198,370.